---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018684"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:11:51.555048+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio shareholders approve reverse stock split of 1:5 to 1:50, board to decide ratio

## Summary
- Three directors re-elected: J.D. Finley (647,086 votes for), Donald Williams (641,789), Emil Chuang (659,895); each had 2,849,169 broker non-votes.
- Baker Tilly ratified as auditor for FY2025 with 3,348,348 votes for, 108,424 against.
- Reverse stock split amendment approved 2,353,265 for to 1,122,616 against; board may set ratio 1:5 to 1:50, implement by Dec 31, 2025.

## SEC filing metadata
- accession: 0001493152-25-018684
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315225018684/0001493152-25-018684-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315225018684/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018684
- JSON: https://secwatch.observer/filing/0001493152-25-018684.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018684.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.